[Function of SIRT6 in tumor initiation and progression]
- PMID: 29019209
- DOI: 10.13345/j.cjb.150403
[Function of SIRT6 in tumor initiation and progression]
Abstract
As a member of the sirtuins family, also called Class III histone deacetylases (HDACs), SIRT6 has many catalytic enzyme activities and plays a pivotal role in biological processes including anti-aging, chromatin regulation, transcriptional control, glucose and lipid metabolism, and DNA damage repair. Recently, increasing evidences indicated that SIRT6 was related to initiation and development of tumors, such as hepatic cancer, lung cancer, breast cancer and genital system tumors. However, SIRT6 might play a dual role in tumorigenesis and progression. SIRT6 often acted as a tumor suppressor, but might play an oncogenic role. Based on our current study, we depicted the essential roles of SIRT6 in the initiation and progression of various tumors, and summarized its mode of actions, which might provide clues for cancer therapy.
SIRT6 作为组蛋白去乙酰化转移酶 (Histone deacetylases，HDACs) 第三家族长寿蛋白 (Sirtuins，SIRTs)中的一员，具有多种催化酶活性，且在抗衰老、染色质调节、转录调控、糖脂代谢、DNA 损伤修复等生物学过程中起着重要的作用。近年来的证据表明，SIRT6 的表达与肿瘤的发生发展密切相关，且在多种肿瘤中起着关键的调节作用，比如肝癌、肺癌、乳腺癌和生殖系统肿瘤等。但是由于SIRT6 功能的多样性，及其上下游信号通路的复杂性，SIRT6 在肿瘤中可能扮演着双重角色。在大多数情况下，SIRT6 扮演着抑癌基因的角色，少数情况下，SIRT6 却又发挥着促癌作用。本文结合目前本实验室的研究，阐述了近几年来关于SIRT6 在多种肿瘤发生及发展中的最新发现，总结了其作用机制，并对其研究及应用前景进行了展望。.
Keywords: SIRT6; Warburg effect; histone deacetylases (HDACs); tumor development; tumor initiation.
Similar articles
-
SIRT6: Novel Mechanisms and Links to Aging and Disease.Trends Endocrinol Metab. 2017 Mar;28(3):168-185. doi: 10.1016/j.tem.2016.10.002. Epub 2016 Nov 9. Trends Endocrinol Metab. 2017. PMID: 27836583 Free PMC article. Review.
-
Sirtuins and SIRT6 in Carcinogenesis and in Diet.Int J Mol Sci. 2019 Oct 7;20(19):4945. doi: 10.3390/ijms20194945. Int J Mol Sci. 2019. PMID: 31591350 Free PMC article. Review.
-
The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism.Cell. 2012 Dec 7;151(6):1185-99. doi: 10.1016/j.cell.2012.10.047. Cell. 2012. PMID: 23217706 Free PMC article.
-
Transcriptional activation of SIRT6 via FKHRL1/FOXO3a inhibits the Warburg effect in glioblastoma cells.Cell Signal. 2019 Aug;60:100-113. doi: 10.1016/j.cellsig.2019.04.009. Epub 2019 Apr 17. Cell Signal. 2019. PMID: 31004738
-
SIRT6 deacetylates PKM2 to suppress its nuclear localization and oncogenic functions.Proc Natl Acad Sci U S A. 2016 Feb 2;113(5):E538-47. doi: 10.1073/pnas.1520045113. Epub 2016 Jan 19. Proc Natl Acad Sci U S A. 2016. PMID: 26787900 Free PMC article.
Cited by
-
Targeting a cryptic allosteric site of SIRT6 with small-molecule inhibitors that inhibit the migration of pancreatic cancer cells.Acta Pharm Sin B. 2022 Feb;12(2):876-889. doi: 10.1016/j.apsb.2021.06.015. Epub 2021 Jul 2. Acta Pharm Sin B. 2022. PMID: 35256952 Free PMC article.
-
Clinicopathological and prognostic value of SIRT6 in patients with solid tumors: a meta-analysis and TCGA data review.Cancer Cell Int. 2022 Feb 16;22(1):84. doi: 10.1186/s12935-022-02511-3. Cancer Cell Int. 2022. PMID: 35172823 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
